Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines
Authors
Keywords
Anticancer, Cytotoxic activity, Semi-synthetic derivative, Ingenol, <em class="EmphasisTypeItalic ">Euphorbia tirucalli</em>
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-02-01
DOI
10.1007/s10637-019-00728-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells
- (2018) Viviane A. O. Silva et al. INVESTIGATIONAL NEW DRUGS
- In�vitro screening of cytotoxic activity of euphol from Euphorbia�tirucalli on a large panel of human cancer‑derived cell lines
- (2018) Viviane Silva et al. Experimental and Therapeutic Medicine
- Ingenol-3-Angelate Suppresses Growth of Melanoma Cells and Skin Tumor Development by Downregulation of NF-κB-Cox2 Signaling
- (2018) Dunwei Wang et al. MEDICAL SCIENCE MONITOR
- Euphorbia neriifolia L.: Review on botany, ethnomedicinal uses, phytochemistry and biological activities
- (2017) Prashant Y. Mali et al. Asian Pacific Journal of Tropical Medicine
- Medicinal plants in Brazil: Pharmacological studies, drug discovery, challenges and perspectives
- (2016) Rafael C. Dutra et al. PHARMACOLOGICAL RESEARCH
- Isolation, characterization and screening of the in vitro cytotoxic activity of a novel L-amino acid oxidase (LAAOcdt) from Crotalus durissus terrificus venom on human cancer cell lines
- (2016) Tuila Leveghim Teixeira et al. TOXICON
- Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker
- (2016) Renato José Silva-Oliveira et al. CELLULAR ONCOLOGY
- Cancer-Associated Protein Kinase C Mutations Reveal Kinase’s Role as Tumor Suppressor
- (2015) Corina E. Antal et al. CELL
- The antinociceptive effects of the tetracyclic triterpene euphol in inflammatory and neuropathic pain models: The potential role of PKCε
- (2015) R.C. Dutra et al. NEUROSCIENCE
- Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ–NF-κB signaling
- (2014) Guochun Jiang et al. AIDS
- The value of nature's natural product library for the discovery of New Chemical Entities: The discovery of ingenol mebutate
- (2014) Steven M. Ogbourne et al. FITOTERAPIA
- Dual Role of Novel Ingenol Derivatives from Euphorbia tirucalli in HIV Replication: Inhibition of De Novo Infection and Activation of Viral LTR
- (2014) Celina M. Abreu et al. PLoS One
- 14-Step Synthesis of (+)-Ingenol from (+)-3-Carene
- (2013) L. Jorgensen et al. SCIENCE
- The role of PKC/ERK1/2 signaling in the anti-inflammatory effect of tetracyclic triterpene euphol on TPA-induced skin inflammation in mice
- (2012) Giselle F. Passos et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Protein kinase C, an elusive therapeutic target?
- (2012) Daria Mochly-Rosen et al. NATURE REVIEWS DRUG DISCOVERY
- Ingenol Mebutate Gel for Actinic Keratosis
- (2012) Mark Lebwohl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unique In Vitro and In Vivo Thrombopoietic Activities of Ingenol 3,20 Dibenzoate, A Ca++-Independent Protein Kinase C Isoform Agonist
- (2012) Frederick K. Racke et al. PLoS One
- Euphol prevents experimental autoimmune encephalomyelitis in mice: Evidence for the underlying mechanisms
- (2011) Rafael Cypriano Dutra et al. BIOCHEMICAL PHARMACOLOGY
- PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: Results of a randomized phase IIa trial
- (2010) Greg Siller et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: Results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study
- (2009) Greg Siller et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Activity of the multikinase inhibitor dasatinib against ovarian cancer cells
- (2009) G E Konecny et al. BRITISH JOURNAL OF CANCER
- Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells
- (2008) M. Serova et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More